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Cadmium and the Kidney
by tars Friberg*
The paper is a review of certain aspects of importance of cadmium and the kidney
regarding the assessment of risks and understanding of mechanisms of action. The
review discusses the following topics: history and etiology of cadmium-induced kidney
dysfunction and related disorders; cadmium metabolism, metallothionein and kidney
dysfunction; cadmium in urine as indicator of body burden, exposure and kidney dys-
function; cadmium levels in kidney and liver as indicators ofkidney dysfunction; charac-
teristics ofearly kidney dysfunction; the critical concentration concept; critical concen-
trations ofcadmium in kidney cortex; and prognosis.
Introduction
Long-term exposure to cadmium via inhalation
oringestion may giverise to kidneydamage, from
minor tubular dysfunctions to severe impairment
involving tubuli as well as glomeruli. Cadmium
induces various other effects; obstructive lung
disease, for example, is common after long-term
inhalation of cadmium. The kidney is, however,
generally believed to be the critical organ (1). If
early signs of kidney dysfunction are prevented,
othertoxic effects will be avoided. The question of
cadmium and cancer is still controversial, but
conclusions have been reached (2,3) that certain
forms ofcadmium exposure may contribute to the
development of cancer of the prostate in man.
Results from recent animal studies (4) have
shown a high and dose-related incidence of pul-
monary cancer in rats exposed for 18 months to a
cadmium chloride aerosol at concentrations be-
tween 12 and 50 jig Cd/m3. That lung cancer in
the future may become a critical effect for certain
forms ofcadmium exposure cannot be excluded.
This presentation is an overview, focusing on
aspects of cadmium and the kidney relevant to
the assessment ofrisks and an understanding of
the mechanisms ofaction. Detailed discussions of
specific areas will be presented in other papers at
this symposium or are summarized in recent re-
views on renal effects ofcadmium by Nomiyama
(5) and Piscator (6). Tsuchiya has reviewed cad-
mium studies inJapan (7). The monograph "Cad-
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mium in the Environment" from our group in
Sweden (8) is now extensively rewritten and up-
dated. The manuscript for a new monograph,
"Cadmium and Health," will be submitted for
publication early 1984 (9). Furthermore, WHO
has issued an interim report of a criteria docu-
ment for cadmium (10,11) and within the Inter-
national Programme for Chemical Safety a new
criteria document on cadmium is in preparation.
History and Etiology of
Cadmium-induced Kidney
Dysfunction and Related
Disorders
At the IXth International Congress on Indus-
trial Medicine in London in 1948, I presented
preliminary results from studies on cadmium-
exposed battery workers. The major signs were
from the kidneys, a tubular and glomerular dys-
function with proteinuria, low concentration ca-
pacity, decreased inulin clearance, and from the
lungs emphysema. These signs were observed
only among workers with several years' employ-
ment (12). At that time it was not possible to
conclude, with certainty, whether cadmium or
nickel was the cause of the disease. Exposure to
both metals had occurred, and there was a lack of
relevant information in the literature. The
results were presented in more detail in 1950. In
collaboration with Ohlhagen it was shown that
the largestcomponent ofthe urinaryproteins had
a low molecular weight. Animal data also defi-
nitely incriminated cadmium as the etiological
agent (13). It is ofinterest to note that there is aL. FRIBERG
report from 1897 (14) describing lead poisoning
among employees in zinc works, where 82% of65
men had proteinuria and 83% emphysema. Al-
ready in 1948 I pointed out that it appeared more
reasonable to consider cadmium the etiological
agent rather than lead. No doubt, there must
have been considerable exposure to cadmium in
the zinc works.
It was some time before the etiology of the
disease was widely recognized. With time, how-
ever, more and more evidence appeared showing
that long-term exposure to cadmium can give rise
to proteinuria and kidney damage in animals as
well as in humans. Reports in the fifties and
sixties by British investigators, such as Adams,
Bonnell, Kazantzis, Potts, and Smith (8) were of
particular importance. They showed that the cad-
mium syndrome had occurred in workers in other
occupations besides those in battery production.
A high prevalence of kidney stones has been
reported in Swedish workers (13,15,16) as well as
those from Britain (17-19). There are no reports
on kidney stones from Belgium or Japan. Other
disorders in mineral metabolism have also been
observed. Kazantzis et al. (20), for example, re-
ported an increased urinary excretion ofcalcium
in workers with kidney dysfunction. One of the
workers later developed osteomalacia (21).
Concern about long-term exposure to cadmium
became more acute after recognition of the Itai-
Itai disease among part ofthe general population
of Japan. The Itai-Itai disease, a multifactorial
disease but where cadmium is a necessary agent,
is a combination of severe kidney damage and
osteomalacia. It has occurred among inhabitants
in certain areas ofToyama prefecture, where rice
had become heavily contaminated due to irriga-
tion of the soil with water contaminated with
cadmium from industrial sources (7,8,10,11).
A number ofcases with osteomalacia following
industrial exposure has also been reported. The
first report was by Nicaud et al. (22), followed by
other reports from France (23,24) and Britain
(21,25).
There are other areas in Japan which have
been contaminated with cadmium to a lesser ex-
tent. A few cases of a similar bone disease have
been reported recently from these areas (26,27).
The disorder included clinical signs, biochemical
findings and cadmium levels almost identical to
those found in the recognized cases of Itai-Itai
disease. In two of the cases autopsies were per-
formed, and liver cadmium levels were very high
(75 and 153 mg Cd/kg) whereas renal cortex cad-
mium levels were low (53 and 24 mg Cd/kg).
These cases have not been acknowledged as Itai-
Itai disease by the authorities. It seems almost as
if a necessary prerequisite for the acknowledg-
ment of a new case of Itai-Itai disease is that it
occurs in an area where Itai-Itai disease previ-
ously occurred. However, this will make it impos-
sible to accept cases outside the Tobyama prefec-
ture.
The occurrence of Itai-Itai disease in certain
areas of Japan constitutes only the top of an
iceberg. An increased prevalence of proteinuria,
in some areas over 50%, hasbeen observed among
the general population in several areas where
exposure to cadmiumthrough consumption ofrice
is high (7,8).
Cadmium Metabolism,
Metallothionein and Kidney
Dysfunction
Cadmium is absorbed both after inhalation and
ingestion. Absorption after inhalation depends on
particle size and solubility and varies between 20
and 50% ofthe amount inhaled (8). The average
absorption after ingestion is approximately 5%
but increases considerably in the presence ofcal-
cium or iron deficiency and may reach values of
up to at least 20% (28,29).
After ingestion, cadmium is transported to the
liver where it stimulates the synthesis of metal-
lothionein. It was suggested by Piscator as early
as 1964 (30) that cadmium is bound to metal-
lothionein and transported via blood to the kid-
neys. Cadmium metallothionein administered
parenterally to animals is transported directly to
the kidneys and has a different toxicity than that
after administration of unbound cadmium (31-
34). Also, oral feeding of mice with cadmium
metallothionein and cadmium chloride, respec-
tively, resulted in a considerably higher cadmium
concentration in the kidneys than in the liver,
despite similar absorption levels (35,36). Recent
data (37) indicate that humans exposed to very
high concentrations ofcadmium bound to metal-
lothionein, as is the case for certain oyster eaters
in New Zealand, will not acquire as high blood
cadmium levels as could be expected from the
high daily intake. On the other hand, there are
indications that the levels of cadmium in the
blood ofsmokers, who as a result ofsmoking are
exposed to a finely dispersed cadmium aerosol,
may be disproportionately high in relation to
kidney levels (38-40). When assessing available
data it seems clear that the chemical form and
exposure route of cadmium is of importance not
only for absorption, but also for distribution inCADMIUMAND THE KIDNEY
the body. This also involves important implica-
tions for the interpretation of blood cadmium
levels in risk estimations.
Following long-term low-level exposure, ap-
proximately one-third ofthe cadmium in the body
will be found in the kidneys, while at higher
exposure proportionately more will be in the liver
(8). The accumulation in the kidneys is explained
by the flow of cadmium via blood through the
kidney where cadmium bound to metallothionein
is filtered with the primary urine and reabsorbed
into the tubular cells as are other low molecular
weight proteins (31,41). The metallothionein cad-
mium molecule is probably taken up into the
tubular cells by pinocytosis (42-44). The reab-
sorption of cadmium metallothionein is almost
complete at low levels of cadmium in plasma,
whereas the reabsorption may be less effective at
high levels ofmetallothionein in plasma (45,46).
A continuous catabolism ofthecadmium metal-
lothionein takes place after reabsorption in the
tubuli and cadmium is split from the metallothio-
nein and bound to newly formed metallothionein
in the tubular cells. It is supposed (8,47,48) that
kidney damage is prevented until a stage is
reached at which the kidneys can no longer pro-
duce enough metallothionein. At this stage the
non-metallothionein-bound cadmium ions will
become very toxic.
Cadmium in Urine as Indicator of
Body Burden, Exposure and
Kidney Dysfunction
Some ofthe cadmium filtered through the glo-
meruli and some of the stored cadmium in the
kidneys is excreted via the urine. With time the
urinary cadmium will be primarily related to cell
cadmium concentration and thus an indicator of
kidney burden. Nordberg (49) found in a chronic
injection exposure experiment onmicethatbefore
tubular proteinuria appeared cadmium excretion
in urine on a group basis was correlated to body
burden, while a large proportion ofthe gastroin-
testinal excretion is directly related to the daily
dose. The increase ofcadmium excretion in urine
with age is obvious in human studies also (50-
53).
Figure 1, from Elinder et al. (52), compares the
variations with age of urinary cadmium, cad-
mium in the kidneys, and daily intake among
nonsmokers. There is a close correlation between
total cadmium (mg) in kidneys and cadmium in
urine (,g/24 hr) but no correlation with daily
fecal cadmium amount as an indication of daily
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FIGURE 1. Comparison between thevariations with age of(e)
urinary cadmium, (0) total amount of cadmium in the
kidney and daily fecal cadmium (52).
intake. If the data are recalculated to ,g Cd/g
kidney cortex and mg Cd/g creatinine in urine
(which were analyzed in the study) and if the
correlation between cadmium in urine and kid-
ney is assumed to hold true up to 200 ,ug Cd/g
kidney cortex, this concentration will correspond
to roughly 10 ,g Cd/g creatinine.
A number of metabolic models have been pro-
posed for cadmium beginning with those of Tsu-
chiya and Sugita (54) and Kjellstrom (55), both of
whom used a one-compartment model to more
sophisticated models by Kjellstrom and Nordberg
(56) and Travis and Haddock (57). The biological
half-time for cadmium is very long-10-30
years-decreasing with increasing age. A half-
time of26 years has been estimated based on a 2-
yr observation period ofa human subject given a
single dose of radioactive cadmium (58). The
models developed so far do not take into consider-
ation situations where exposure is not to long-
term low levels, but instead to heavy exposure
which occurs in certain industries. Under heavy
exposure conditions, the excretion ofcadmium in
urine mav be higher and does not follow the
general model, as reported by Piscator (59) and
Lauwerys et al. (60). Furthermore, excretion of
cadmium in urine increases dramatically when
kidney damage occurs. This was shown in rabbits
as early as 1952 (61) and has since been con-
firmed in many species, including man (8,9).
Thus, if the excretion of cadmium in urine is
higher than would correspond to an estimated
kidneyburden, it should alwaysbe suspectedthat
the high urinary excretion is due to kidney dys-
function.
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FIGURE 2. Renal cortex cadmium concentrations as a func-
tion ofrenal effects observed (62): (0) industrial exposure;
(o) general environmental exposure. *For cases with gen-
eral environmental exposure, a minus in most cases indi-
cates that data on proteinuria were not available.
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FIGURE 3. Cadmium concentrations in renal cortex from (e)
normal human beings in different age groups (mean val-
ues), (A) exposed workers (single values) and (O) Itai-Itai
patients (single values). Logarithmic scale (8). (I) Kana-
zawa, Japan; (II) Kobe, Japan; (III) U.S.A.; (IV) U.K.; (V)
Sweden (2 areas).
0 25 50 75
age inyears
FIGURE 4. Cadmium concentrations in liver from (e) normal
human beings in different age groups (mean values), (A)
exposed workers (single values) and (C) Itai-Itai patients
(single values). Logarithmic scale (8). (I) Kanazawa, Ja-
pan; (II) Kobe, Japan; (III) U.S.A.; (IV) U.K.; (V) Sweden (3
areas); (VI) Tlkyo, Japan.
Cadmium Levels in Kidney and
Liver as Indicators of Kidney
Dysfunction
After some time the increased cadmium excre-
tion due to kidney damage gives rise to a typical
distribution pattern of cadmium in the body. In
advanced cases ofcadmium intoxication one will
find high liver values in combination with low
kidney values. The kidney values, in fact, may
well be comparable with values found in persons
in the general population without known exces-
sive exposure to cadmium. In Figure 2, Kjell-
strom (62) has compiled renal cortex concentra-
tions as a function of renal effects in 42 cases,
industrially exposed and subjects from the gen-
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FIGURE 5. Cadmium concentrations in liver and kidney cortex ofcadmium workers with and (o) without proteinuria (67,69).
eral population. Generally speaking, subjects
with both proteinuria and severe morphological
changes had on an average considerably lower
kidney cortex concentrations than did other sub-
jects. For a number of cases kidney as well as
liver concentrations are available; Figures 3 and
4, from Friberg et al. (8), show the typical combi-
nation oflow kidney levels and high liver levels.
Recent studies using in vivo neutron activation
analysis (63-65) have increased the possibilities
to study relationships between renal cadmium
levels and kidney dysfunction as well as between
renal cadmium and liver cadmium levels (66-69).
Figure 5 shows that in most cases with high liver
concentrations the kidney cortex level is dispro-
portionately low. In addition, many of these
workers had increased urinary f32-microglobulin
excretion.
In advanced cases, kidney damage involves
both the tubular and glomerular function. This
has been observed following both occupational
exposure and exposure from the general environ-
ment in Japan (8,13).
Characteristics of Early Kidney
Dysfunction
In the 1940s and 1950s, no elaborate methods
were available to characterize the proteinuria in
detail. The proteinuria in the Swedish battery
workers, however, was found to differ from com-
mon proteinuria in that it displayed different
precipitation reactions. Furthermore, it was
shown that the main component of the urinary
proteins had a considerably lower molecular
weight than albumin (13). Subsequent studies by
Piscator (70) and Kazantzis et al. (20) showed
that an early sign ofkidney damage in cadmium
intoxication is a tubular dysfunction similar to
the one described by Butler and Flynn (71). Most
researchers in the field now agree that cadmium
damage istypically located inthe proximal tubuli
resulting in decreased reabsorption of proteins.
However, there isstill notcomplete agreement. In
a number ofpublications from the Belgian group
(72-75), high urinary excretion, not only of low
molecular weight proteins, but also oflarger pro-
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5teins such as albumin were interpreted as a sign
of a primary glomerular damage caused by cad-
mium. The question of glomerular or tubular
etiology ofthe early cadmium proteinuria will be
discussed in detail in other presentations at this
meeting. The fact that albumin occurs as part of
the proteinuria is not, as such, proof of primary
glomerular damage. In normal serum, albumin
occurs to a much greater extent than low molecu-
lar weight proteins. Despite the fact that only a
small proportion of albumin is filtered through
the glomeruli (76), the absolute amount filtered is
still higher than the amount of, e.g., P2-microglo-
bulin. Due to an efficient reabsorption in the
tubuli ofall proteins, only a small fraction ofthe
proteins will be excreted inthe normal urine. The
albumin excretion in urine is, however, still con-
siderably greater than the excretion oflow molec-
ular weight protein. Mogensen and S0lling (77)
have shown in studies on human volunteers that
intravenous administration of lysine, which re-
versibly inhibits the tubular reabsorption, gives
rise to a dramatic increase in several proteins in
the urine. Albumin increased about 40 times,
while P2-microglobulin increased about 1500
times. Thus, it is to be expected that a tubular
dysfunction due to cadmium will give rise to an
increase in the excretion ofboth albumin and low
molecular weight proteins. The absolute increase
will be highest for albumin, but the relative in-
crease will be highest for low molecular weight
proteins (6,62). Nowadays quantitative analysis
ofcertain low molecular weight proteins is possi-
ble. Most studies have concentrated on the excre-
tion of ,32-microglobulin (78,79). Bernard and co-
workers have paid particular attention to the
determination of retinol-binding proteins and
have presented methods for routine analyses of
these proteins (80). The determination ofretinol-
binding proteins has certain advantages over 2-
microglobulin analysis, as there is an absence of
interference from the pH ofthe urine.
The Critical Concentration
Concept
An issue of particular importance is the dose
level at which cadmium gives rise to the first
adverse effects in humans. As the kidney is the
critical organ, it is of particular interest to esti-
mate the critical concentration inthis organ. This
concentration is established on an individual ba-
sis and varies between individuals. The dose-
response relationship which expresses the re-
sponse of the particular effect as a function of
metal concentration in the critical organ displays
the frequency distribution of individual critical
concentrations.
The concept of critical concentration has been
used in risk estimations to establish "acceptable"
levels of a metal in the critical organ. Relation-
ships between concentrations in the critical or-
gan, indicator media, such as urine and blood, as
well as acceptable concentrations in air and food,
may be established by using a metabolic model.
In recent years there has been some confusion
over the concept "critical concentration." As a
rule, a single number for the critical concentra-
tion has been used, thus, omitting consideration
of differences in metabolism and sensitivity. In
the World Health Organization criteria docu-
ments, reference is made to "earliest effect level"
formercury (81), "no detected effect level" for lead
(82), and "critical concentration" for cadmium
(11). The Commission ofthe European Communi-
ties has used the term "no effect level" in their
cadmium document (83). As a rule these terms
are not well defined and it is not known to what
extent they refer to individuals or groups. For
cadmium specifically, a WHO Task Group for the
preparation of the Environmental Health Crite-
ria for Cadmium (10,11) has concluded that the
critical concentration is between 100 and 300 ,ug/
g, but that the most likely estimate is about 200
,/g wet weight. In our 1974 review (8) we also
considered itjustified to start out from a value of
200 p,g/g in renal cortex. We pointed out, how-
ever, that this did not imply that 200 ,ug/g would
give rise to renal tubular dysfunction in all ex-
posed persons. As always inbiological experience,
at a certain low concentration only a fraction of
an exposed population will show signs of effects.
This fraction was, however, not defined and this
omission has probably led to misunderstanding.
Taking this as a background, "a population criti-
cal concentration" (PCC) has been proposed (84).
A PCC-50 would be the concentration in the criti-
cal organ at which 50% ofthe population exhibits
the critical effect; i.e., they have exceeded their
individual critical concentrations. In risk evalua-
tions one will have to decide the maximum ac-
ceptable response rate based on a risk estimation.
If5% is the maximum, then the PCC-5 has to be
established, etc.
Critical Concentrations of
Cadmium in Kidney Cortex
The type of data available for estimation of
critical concentrations stems partly from animal
experiments and partly from experience with hu-
mans. The latter data are based on autopsy stud-
6 L. FRIBERGCADMIUM AND THE KIDNEY
ies as well as on in vivo measurements of cad-
mium in human kidney and liver in combination
with studies on different effect parameters, such
as proteinuria, which have been carried out in
recent years.
As discussed above, autopsy and biopsy data
have revealed much lower cadmium levels in
kidneys among people with severe renal damage
(Fig. 2). This evidence wastaken as abasis forthe
evaluation within the WHO Task Group.
Techniques for in vivo measurements of cad-
mium in human kidney and liver are now avail-
able (63-65). There is still much to be desired
from the point of view of quality control of the
data generated from such studies. For example,
there have been no studies in which concentra-
tions of cadmium have been monitored (e.g., in
cadavers) using both neutron activation in vivo
and conventional analytical techniques. Never-
theless, there is good reason to believe that the
data reported in two studies by Roels et al. (67-
69) and Ellis et al. (66) are accurate enough to
permit important conclusions to be drawn. Based
on cadmium analyses in liver and kidney and
data on renal tubular damage, these authors re-
ported on critical concentrations in the kidney. In
the report by Ellis et al., the critical concentra-
tion based on measurements in whole kidney was
estimated to be 319 + 93 mg Cd/kg kidney cortex.
Roels et al. (69), correcting their original data
(67) for an error in the measurement, calculated
the mean renal cortex cadmium concentration to
be 332 mg Cd/kg. They also reported that a value
correspondingto 216 mgCd/kgorlesswould show
an effect in 10% ofthe workers. The data ofEllis
et al. (66) are notpresented in away whichmakes
possible an evaluation of the response rate at
different concentrations. The mean value, how-
ever, should correspond to a PCC-50. There was
also considerable variance in the individual val-
ues and according to Ellis (personal communica-
tion to Kjellstrom) the 95% tolerance interval is
in the range +90 mg from the mean.
A recent paper by Kjellstrom et al. (85) on
conceptual problems in establishing the critical
concentration of cadmium in human kidney cor-
tex reports that there is a possible error in the
factor 1.5, commonly used in calculating concen-
trations in the kidney cortex from levels in the
whole kidney. This factor was based on an equal
mass ofcortex and medulla and concentrations in
cortex twice those in medulla. The assumption
that, on an average, concentrations of cadmium
in cortex are twice those in medulla is still rea-
sonable, although individual variations may be
considerable (86). There seems to be no support
for an equal mass for cortex and medulla, how-
ever, and even if there were, the factor would
become 1.3 instead of1.5. A factor of1.5 has been
repeatedly used by several authors, since it was
first introduced by Kjellstrom (55) and Friberg et
al. (87). In a report of the Task Group on Refer-
ence Man by ICRP (88), the volume ofthe cortex
in one human kidney is given as 70% ofthe total.
In two dogs, corresponding values were 70 and
75%, respectively. Ifthe mass ofthe cortex is, say
75% ofthe total mass, this would correspond to a
factor of 1.15 when recalculating whole kidney
values to cortex values. In order to obtain a factor
of1.5 one would have to assume that the cortex is
only about 30% of the total kidney. Preliminary
studies (Svartengren et al., unpublished data)
carried out atourInstitute on seven subjectshave
given results which support the assumption that
the factor of 1.5 should be reduced considerably,
possibly to 1.15 on an average. Extended studies
are under way. There appears to be considerable
individual variation. It certainly seems impor-
tant to look into this question ip more detail both
by measuring the mass of the different kidney
compartments and by cadmium analysis ofwhole
kidney as well as the different kidney compart-
ments. The use of a factor 1.15 instead of 1.5 in
the studies by Roels et al. (67-69) and Ellis et al.
(66) would reduce the PCC-50 to approximately
240 jig Cdlg wet weight and the PqC-10 to ap-
proximately 160 ,ug Cd/g.
Individual critical concentrations have not
been calculated in animal studies, and values are
oftenbasedonsmall groups ofanimals. Reports of
effects occurring at certain concentrations should
usually be interpreted as concentrations at which
at least 50% ofthe animals were affected. When
only a small number of animals are tested, the
confidence intervals will be very great. Small
groups can only be used to measure very high
response rates.
A large number of animal studies have been
carried out which have resulted in data on both
cadmium concentrations in renal cortex an&oc-
currence of tubular damage. These studies are
summarized in our new cadmium monograph (9).
It can be seen that studies have been carried out
on several species. With few exceptions, effects
have been observed at average renal cortex con-
centrations of200-300 mg Cd/kg wet weight, but
some effects have also been reported at considera-
bly lower concentrations (89,90). Studies on rhe-
sus monkeys by Nomiyama et al. (91), on the
other hand, are reported to show effects first at
higher concentrations. Althoughthe numbers are
small and some data due to methodological prob-
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FIGURE 6. Albuminuria before and after removal from cad-
mium exposure: (0) none of the biological parameters of
renal function abnormal; (0) at least one of the renal
biological parameters abnormal (98).
lems are difficult to interpret, some ofthe exposed
monkeys had extremely high concentrations, i.e.,
800-1000 mg Cd/kg, in renal cortex. Similar lev-
els have not been reported in other species. It is
possible that the rhesus monkey is not a suitable
animal model for studying cadmium nephrotoxic
effects. Another monkey, the marmoset monkey,
has been shown to differ from all other species
studied in relation to arsenic metabolism (92,93).
Such species on the other hand are ofinterest as
they canbe ofvalue in elucidating mechanisms of
toxicity.
Prognosis
It is well established that long-term exposure
to high concentrations of cadmium may lead not
only to slight kidney dysfunction but also to renal
disease characterizedby severe tubular as well as
glomerular disorders. This obviously implies a
nisk for overt disease, invalidity and even death.
A higher than expected mortality rate, including
an increased mortality in renal disease, has been
observed in Swedish workers exposed to high
concentrations of cadmium (8,94). In a recent
FIGURE 7. 02-microglobulinuria before and after removal
from cadmium exposure: (0) none ofthe biological parame-
ters ofrenal function abnormal; (-) at least one ofthe renal
biological parameters abnormal (98).
study which examined a large number ofBritish
cadmium workers (95), only a nonsignificant in-
crease in death due to nephritis or nephrosis was
found in a subgroup subject to high exposure.
There are no data from studies in which less
severe consequences have been examined, e.g.,
the need for sick leave or hospitalization.
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Although the critical concentration in an organ
is considered reached even if the changes are
reversible (1), to what extentthe proteinuria may
bereversible is aquestion ofimportance. Swedish
studies (96,97) indicate that the proteinuria was
persistent for several years after cessation of ex-
posure. In a recent study of Belgian workers by
Roels et al. (98), neither total proteinuria nor 12-
microglobulin decreased over a 4-yr period after
cessation ofexposure (Figs. 6 and 7). In fact, three
of eleven workers with normal levels of 032-mi-
croglobulin in urine before removal from work
developed abnormal levels later. Against these
studies there is only one Japanese report (99) in
which five workers who had shown proteinuria
during cadmium exposure 10 yr after cessation
showed negative proteinuria on qualitative tests.
However, two ofthe workers still showed a high
urinary P2-microglobulin level. In summary, it
seems obvious that cadmium-induced tubular
proteinuria is irreversible in most workers, at
least for several years. This also agrees with data
on the metabolism ofcadmium, showing a build-
up of high cadmium levels in the kidneys long
after cessation ofexposure.
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